Christina Pecoraro
Medical · Bellmore, NYNPI 1588831325
Payments from drug & device makers
Across 199 payments — averaging $22.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$675
- AbbVie$462
- Sumitomo Pharma America, Inc.$429
- Exeltis, USA Inc.$399
- Myovant Sciences Inc.$377
- Hologic Sales And Service, LLC$251
- plus $2K from 20 others
What the payments were for
- Food & beverage$4,429100%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 23 | $675 |
| AbbVie | 22 | $462 |
| Sumitomo Pharma America, Inc. | 15 | $429 |
| Exeltis, USA Inc. | 18 | $399 |
| Myovant Sciences Inc. | 12 | $377 |
| Hologic Sales And Service, LLC | 10 | $251 |
| Organon | 16 | $231 |
| Pfizer | 11 | $205 |
| Evofem Biosciences, Inc. | 13 | $198 |
| Millicent US Inc | 9 | $187 |
| Merck | 8 | $166 |
| Coopersurgical, Inc. | 7 | $164 |
| Agile Therapeutics, Inc. | 7 | $119 |
| Therapeuticsmd, Inc. | 4 | $77 |
| Biogen | 3 | $72 |
| Astellas Pharma US Inc | 3 | $64 |
| Scynexis, Inc. | 3 | $52 |
| Amgen | 3 | $50 |
| Octapharma USA, Inc. | 2 | $49 |
| Shield Therapeutics Inc | 2 | $46 |
| Bayer | 2 | $41 |
| Lupin Inc. | 2 | $38 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Smith+Nephew | 1 | $25 |
| Exact Sciences | 1 | $24 |
| Avion Pharmaceuticals | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,445 in reported general payments places this provider in the 85th percentile of 2,395 medical providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 20 | $959 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 19 | $208 |
| ValacyclovirValacyclovir Hcl | 12 | $192 |
| Metronidazole | 11 | $185 |
| Nystatin | 14 | $152 |
| Fluconazole | 21 | $76 |
| Triamcinolone Acetonide | 18 | $51 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $20 |
Paid to pharmacies, not to this prescriber.
Other medical in Bellmore
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
- Ilse StraussSmithtown$87K
- Helen AdamsNew York$87K
- Hailey BrickmanNew York$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.